HHMI
IDXX icon

Howard Hughes Medical Institute’s Idexx Laboratories IDXX Stock Holding History

Howard Hughes Medical Institute’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-17
Closed -$11.5K – 257
2025
Q4 		$11.5K Hold
17
– – 0.01% 190
2025
Q3 		$10.9K Hold
17
– – 0.01% 201
2025
Q2 		$9.12K Buy
+17
New +$8.13K ﹤0.01% 222

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Howard Hughes Medical Institute's IDXX Position: Q1 2026 in Review

Howard Hughes Medical Institute sold out of Idexx Laboratories (IDXX) in Q1 2026, closing a stake of 17 shares — an estimated $11.5K sold.

Howard Hughes Medical Institute first reported a position in IDXX in Q2 2025 and held it in 3 quarters. The position peaked at $11.5K in Q4 2025. 1,316 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

  • Howard Hughes Medical Institute reported no remaining Idexx Laboratories position as of Q1 2026 after selling out during the quarter.
  • Howard Hughes Medical Institute sold 17 Idexx Laboratories shares in Q1 2026, an estimated $11.5K.
  • Howard Hughes Medical Institute first reported a position in Idexx Laboratories in Q2 2025 and held it in 3 quarters.
  • Howard Hughes Medical Institute's Idexx Laboratories position peaked at $11.5K in Q4 2025.
  • 1,316 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on Howard Hughes Medical Institute's 13F filing for Q1 2026, filed 15 May 2026.